Leading Futurist to Highlight Biotechnology's Industrial Revolution at Florida ConferenceMar 15 2004
WASHINGTON, D.C. (March 15, 2004) — Renowned technology forecaster and futurist Daniel Burrus will discuss how biotechnology is revolutionizing industrial processes in ways that will benefit... |
|
'McClellan Will Provide Necessary Leadership to Implement Medicare Law'Mar 12 2004
WASHINGTON, D.C. (March 12, 2004) — Biotechnology Industry Organization (BIO) President Carl B. Feldbaum issued the following statement following last night's Senate confirmation of Mark B.... |
|
Patent Fee Bill Will Help Ensure Continued Biotech InnovationMar 4 2004
WASHINGTON, D.C. (March 4, 2004) - Biotechnology Industry Organization (BIO) President Carl B. Feldbaum issued the following statement following House passage of the United States Patent and... |
|
Biotech's Helix Award Honors Top Performers Onyx Pharmaceuticals and ActelionFeb 25 2004
NEW YORK (February 25, 2004) - Onyx Pharmaceuticals Inc. and Actelion Ltd. have won the 2004 James D. Watson Helix Awards. The winners, selected by peer vote on the basis of their 2003 performance... |
|
Record Numbers Turn out for BIO CEO and Investor ConferenceFeb 25 2004
NEW YORK (February 25, 2004) - More than 2,000 institutional and venture capital investors, business executives, industry analysts and media attended the BIO CEO and Investor Conference, which... |
|
Biotech's Helix Award Honors GenentechFeb 24 2004
NEW YORK (February 24, 2004) - Genentech has won the 2004 James D. Watson Helix Award in the large-cap category and is being honored this afternoon at a BIO CEO & Investor Conference plenary... |
|
'McClellan Wasted No Time Setting New Course for FDA'Feb 20 2004
WASHINGTON, D.C. (February 20, 2004) — Biotechnology Industry Organization (BIO) President Carl B. Feldbaum issued the following statement on today's announcement by President Bush to nominate Food... |
|
BIO CEO & Investor Conference Will Cover the Latest Trends in Science, Medicine and Biotech BusinessFeb 19 2004
WASHINGTON, D.C. (February 19, 2004) - This year's BIO CEO & Investor Conference features 39 panel discussions, including a new series of Therapeutic & Technology Focus Sessions, in addition to the... |
|
More Than 200 Biotech Companies Slated to Present At the BIO CEO & Investor ConferenceFeb 19 2004
WASHINGTON, D.C. (February 19, 2004) - Executives representing more than 400 biotechnology and pharmaceutical companies from around the world will gather Feb. 23 - 25 at the Waldorf=Astoria Hotel... |
|
Personalized Medicine, Financial Sessions on Tap At BIO's CEO & Investor Conference in New YorkFeb 17 2004
WASHINGTON, D.C. (February 17, 2004) — Executives and scientists from leading biotech and pharmaceutical companies will discuss "The Promise of Personalized Medicine" Wednesday, Feb. 25, at the... |
